In vitro, it has been demonstrated that IL-10 upregulates KPNA2 (a gene coding for nuclear import of proteins); at the same time, knockdown experiments showed that glioma cell growth and invasion were significantly reduced, suggesting IL-10 as a potential target for glioma patients’ treatment [162]. Here, IL10 is linked to central nervous system cancer.